Report cover image

Cardiac Markers Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Jun 20, 2022
Length 107 Pages
SKU # GBDT17342744

Description

Cardiac Markers Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Cardiac Markers Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Cardiac Markers Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Markers Rapid Tests & Point of Care (POC) are rapid diagnostic tests which are simple to perform, ready to use, accurate, economic and for infield use suggested for individuals suspected with any indication.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Markers Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to-
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

107 Pages
2 Table of Contents
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Cardiac Markers Rapid Tests & POC Overview
4 Products under Development
4.1 Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
4.2 Cardiac Markers Rapid Tests & POC - Pipeline Products by Segment
4.3 Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
4.4 Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
4.5 Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date
5 Cardiac Markers Rapid Tests & POC - Pipeline Products under Development by Companies
5.1 Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
5.2 Cardiac Markers Rapid Tests & POC – Companies Pipeline Products by Stage of Development
6 Cardiac Markers Rapid Tests & POC Companies and Product Overview
6.1 1Drop Diagnostics Company Overview
6.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
6.2 Abbott Point of Care Inc Company Overview
6.2.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 Accel Diagnostics LLC Company Overview
6.3.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
6.4 Alfa Wassermann Inc Company Overview
6.4.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Angle Biosciences Inc Company Overview
6.5.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.6 Anteo Technologies Pty Ltd Company Overview
6.6.1 Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.7 Atonomics A/S (Inactive) Company Overview
6.7.1 Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.8 Axis-Shield Diagnostics Ltd Company Overview
6.8.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.9 BBB Technologies Inc Company Overview
6.9.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.10 Bio-AMD Inc Company Overview
6.10.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 BiOracle Ltd (Inactive) Company Overview
6.11.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.12 Biosensia Ltd Company Overview
6.12.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 Biostealth, Inc. Company Overview
6.13.1 Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.14 Biosurfit, SA Company Overview
6.14.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
6.15 Bluejay Diagnostics Inc Company Overview
6.15.1 Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.16 Boditech Med Inc Company Overview
6.16.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Carclo Diagnostic Solutions Ltd Company Overview
6.17.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.18 CardioGenics Inc Company Overview
6.18.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 Coris BioConcept Company Overview
6.19.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
6.20 Diazyme Laboratories Inc Company Overview
6.20.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
6.21 Duke University Company Overview
6.21.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
6.22 Dynasil Corporation of America Company Overview
6.22.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
6.23 Eachy Biopharmaceuticals Ltd Company Overview
6.23.1 Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.24 ET Healthcare Inc Company Overview
6.24.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
6.25 genedrive plc Company Overview
6.25.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
6.26 Group K Diagnostics Company Overview
6.26.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
6.27 LeukoDx Ltd Company Overview
6.27.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.28 LumiraDx Ltd Company Overview
6.28.1 LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.29 Maxim Biomedical Inc Company Overview
6.29.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.30 MML Ltd Company Overview
6.30.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.31 Mylab Discovery Solutions Pvt Ltd Company Overview
6.31.1 Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.32 MyMD Pharmaceuticals, Inc Company Overview
6.32.1 MyMD Pharmaceuticals, Inc Pipeline Products & Ongoing Clinical Trials Overview
6.33 Nanomix Inc Company Overview
6.33.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
6.34 Novartis AG Company Overview
6.34.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
6.35 Ohmx Corp Company Overview
6.35.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
6.36 OPKO Health Inc Company Overview
6.36.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
6.37 Proxim Diagnostics Corp Company Overview
6.37.1 Proxim Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
6.38 Radiometer Medical ApS Company Overview
6.38.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
6.39 Radisens Diagnostics Ltd Company Overview
6.39.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.40 Resdin Technologies Inc. Company Overview
6.40.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.41 Salignostics Ltd Company Overview
6.41.1 Salignostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.42 Sandia National Laboratories Company Overview
6.42.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview
6.43 Sarissa-Biomedical Ltd Company Overview
6.43.1 Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.44
6.45 SpinChip Diagnostics AS Company Overview
6.45.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
6.46 Thermo Fisher Scientific Inc Company Overview
6.46.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
6.47 ThreeFold Sensors (Inactive) Company Overview
6.47.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.48 Trinity Biotech Plc Company Overview
6.48.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
6.49 True Diagnostics Inc Company Overview
6.49.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.50 Upstream Medical Technologies Ltd Company Overview
6.50.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Cardiac Markers Rapid Tests & POC- Recent Developments
7.1 Dec 15, 2021: Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
7.2 Sep 01, 2021: BioMerieux announce First-Half 2021 Results
7.3
7.4 Jul 16, 2021: Trinity Biotech Provides a Business Development Update For Q2 2021
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Cardiac Markers Rapid Tests & POC - Pipeline Products by Segment
Table 3: Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
Table 4: Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 5: Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Markers Rapid Tests & POC – Companies Pipeline Products by Stage of Development
Table 8: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: One Drop Diagnostic Device - Cardiovascular Disease - Product Status
Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Description
Table 11: Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: i-STAT TnI-Nx - Product Status
Table 13: i-STAT TnI-Nx - Product Description
Table 14: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 15: pScreen BNP - Product Status
Table 16: pScreen BNP - Product Description
Table 17: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: ACE Alera Clinical Chemistry System - hsCRP - Product Status
Table 19: ACE Alera Clinical Chemistry System - hsCRP - Product Description
Table 20: ACE Axcel Clinical Chemistry System - hsCRP - Product Status
Table 21: ACE Axcel Clinical Chemistry System - hsCRP - Product Description
Table 22: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Cardiac Troponin Biomarker Kit - Product Status
Table 24: Cardiac Troponin Biomarker Kit - Product Description
Table 25: Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 26: AtomoRapid - Heart Attack - Product Status
Table 27: AtomoRapid - Heart Attack - Product Description
Table 28: Atonomics A/S (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Premium Trace - B-Type Natriuretic Peptide Assay - Product Status
Table 30: Premium Trace - B-Type Natriuretic Peptide Assay - Product Description
Table 31: Trace - D-Dimer Test - Product Status
Table 32: Trace - D-Dimer Test - Product Description
Table 33: Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Afinion hsCRP Assay - Product Status
Table 35: Afinion hsCRP Assay - Product Description
Table 36: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Mark-B - D-dimer Test - Product Status
Table 38: Mark-B - D-dimer Test - Product Description
Table 39: Mark-B - Myoglobin Test - Product Status
Table 40: Mark-B - Myoglobin Test - Product Description
Table 41: markB - CK-MB Test - Product Status
Table 42: markB - CK-MB Test - Product Description
Table 43: markB - cTnl Test - Product Status
Table 44: markB - cTnl Test - Product Description
Table 45: markB - Galectin-3 Test - Product Status
Table 46: markB - Galectin-3 Test - Product Description
Table 47: markB - hsCRP Test - Product Status
Table 48: markB - hsCRP Test - Product Description
Table 49: markB - NT-proBNP Test - Product Status
Table 50: markB - NT-proBNP Test - Product Description
Table 51: markB - ST2 Test - Product Status
Table 52: markB - ST2 Test - Product Description
Table 53: Mobile RDT Reader - Troponin-I Test - Product Status
Table 54: Mobile RDT Reader - Troponin-I Test - Product Description
Table 55: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Digital Strip Reader - Cardiac Marker Test - Product Status
Table 57: Digital Strip Reader - Cardiac Marker Test - Product Description
Table 58: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Status
Table 59: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Description
Table 60: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Status
Table 61: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Description
Table 62: Magnetic Immunoassay Detection System - CK MB - Product Status
Table 63: Magnetic Immunoassay Detection System - CK MB - Product Description
Table 64: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 65: biO1042 Test - Product Status
Table 66: biO1042 Test - Product Description
Table 67: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 68: RapiPlex - Myoglobin Assay - Product Status
Table 69: RapiPlex - Myoglobin Assay - Product Description
Table 70: Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Point-Of-Care Assay - B-Type Natriuretic Peptide - Product Status
Table 72: Point-Of-Care Assay - B-Type Natriuretic Peptide - Product Description
Table 73: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Spinit - D-dimer Test - Product Status
Table 75: Spinit - D-dimer Test - Product Description
Table 76: Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Symphony hsTNT/I - Product Status
Table 78: Symphony hsTNT/I - Product Description
Table 79: Symphony NT-pro BNP - Product Status
Table 80: Symphony NT-pro BNP - Product Description
Table 81: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: AFIAS 1 - POC ST2 Assay - Product Status
Table 83: AFIAS 1 - POC ST2 Assay - Product Description
Table 84: AFIAS 6 - POC ST2 Assay - Product Status
Table 85: AFIAS 6 - POC ST2 Assay - Product Description
Table 86: Ichroma 10 - ST2 Assay - Product Status
Table 87: Ichroma 10 - ST2 Assay - Product Description
Table 88: Ichroma II - POC ST2 Assay - Product Status
Table 89: Ichroma II - POC ST2 Assay - Product Description
Table 90: Ichroma III - ST2 Assay - Product Status
Table 91: Ichroma III - ST2 Assay - Product Description
Table 92: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Micropoc-pro - Troponin-I Assay - Product Status
Table 94: Micropoc-pro - Troponin-I Assay - Product Description
Table 95: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Heart Failure Genomics Risk Test - Product Status
Table 97: Heart Failure Genomics Risk Test - Product Description
Table 98: Heart Failure Risk Stratification Test - Product Status
Table 99: Heart Failure Risk Stratification Test - Product Description
Table 100: Troponin-I Test - Product Status
Table 101: Troponin-I Test - Product Description
Table 102: Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Microfluidic Chip - Product Status
Table 104: Microfluidic Chip - Product Description
Table 105: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 106: ProADM Point-of-Care - Product Status
Table 107: ProADM Point-of-Care - Product Description
Table 108: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction - Product Status
Table 110: Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction - Product Description
Table 111: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Diagnostic Test - Cardiovascular Risk - Product Status
Table 113: Diagnostic Test - Cardiovascular Risk - Product Description
Table 114: Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Combination Kit - ACS - Product Status
Table 116: Combination Kit - ACS - Product Description
Table 117: Home Test Kit - ACS - Product Status
Table 118: Home Test Kit - ACS - Product Description
Table 119: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 120: Pylon Assay - High-Sensitivity C-reactive Protein - Product Status
Table 121: Pylon Assay - High-Sensitivity C-reactive Protein - Product Description
Table 122: Pylon Assay - NT-ProBNP - Product Status
Table 123: Pylon Assay - NT-ProBNP - Product Description
Table 124: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Genedrive - Stroke Marker Test - Product Status
Table 126: Genedrive - Stroke Marker Test - Product Description
Table 127: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Multidiagnostic - BNP Test - Product Status
Table 129: Multidiagnostic - BNP Test - Product Description
Table 130: Multidiagnostic - Troponin T And I Test - Product Status
Table 131: Multidiagnostic - Troponin T And I Test - Product Description
Table 132: LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 133: Accellix Disposable Cartridges Test - Heart Disease - Product Status
Table 134: Accellix Disposable Cartridges Test - Heart Disease - Product Description
Table 135: LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 136: LumiraDx - High Sensitivity Troponin I Test - Product Status
Table 137: LumiraDx - High Sensitivity Troponin I Test - Product Description
Table 138: Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 139: Diagnostic Kit - Cardiovascular Diseases - Product Status
Table 140: Diagnostic Kit - Cardiovascular Diseases - Product Description
Table 141: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 142: MIDS Cardiac - Troponin Test - Product Status
Table 143: MIDS Cardiac - Troponin Test - Product Description
Table 144: Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 145: Diagnostic Kit - Cardiac Disease - Product Status
Table 146: Diagnostic Kit - Cardiac Disease - Product Description
Table 147: MyMD Pharmaceuticals, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Diagnostic Test - Heart Attack - Product Status(MyMD Pharmaceuticals, Inc)
Table 149: Diagnostic Test - Heart Attack - Product Description(MyMD Pharmaceuticals, Inc)
Table 150: Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 151: eLab Critical Cardiac Test - Product Status
Table 152: eLab Critical Cardiac Test - Product Description
Table 153: Omega-3 Cardiac Panel - Product Status
Table 154: Omega-3 Cardiac Panel - Product Description
Table 155: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 156: Diagnostic Test - Cardiac Panel - Product Status
Table 157: Diagnostic Test - Cardiac Panel - Product Description
Table 158: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 159: Diagnostic Assay - hs Troponin I - Product Status
Table 160: Diagnostic Assay - hs Troponin I - Product Description
Table 161: Diagnostic Test - hsCRP - Product Status
Table 162: Diagnostic Test - hsCRP - Product Description
Table 163: Portable POC System - BNP - Product Status
Table 164: Portable POC System - BNP - Product Description
Table 165: Portable POC System - CRP - Product Status
Table 166: Portable POC System - CRP - Product Description
Table 167: Portable POC System - hs Troponin I - Product Status
Table 168: Portable POC System - hs Troponin I - Product Description
Table 169: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 170: Diagnostic Assay - CTnl - Product Status
Table 171: Diagnostic Assay - CTnl - Product Description
Table 172: Proxim Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 173: POC Immunodiagnostic System - D-Dimer - Product Status
Table 174: POC Immunodiagnostic System - D-Dimer - Product Description
Table 175: POC Immunodiagnostic System - hs-cTnl - Product Status
Table 176: POC Immunodiagnostic System - hs-cTnl - Product Description
Table 177: POC Immunodiagnostic System - NT-proBNP - Product Status
Table 178: POC Immunodiagnostic System - NT-proBNP - Product Description
Table 179: Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
Table 180: AQT90 FLEX - BNP Test - Product Status
Table 181: AQT90 FLEX - BNP Test - Product Description
Table 182: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 183: Gemini - Cardiovascular Disease Panel - Product Status
Table 184: Gemini - Cardiovascular Disease Panel - Product Description
Table 185: Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 186: Quick At-Home Diagnostic Test - Myocardial Infarction - Product Status
Table 187: Quick At-Home Diagnostic Test - Myocardial Infarction - Product Description
Table 188: Salignostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 189: Rapid Diagnostic Test - Cardiac Risk - Product Status
Table 190: Rapid Diagnostic Test - Cardiac Risk - Product Description
Table 191: Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 192: RapiDx Assay - BNP - Product Status
Table 193: RapiDx Assay - BNP - Product Description
Table 194: RapiDx Assay - CK-MB - Product Status
Table 195: RapiDx Assay - CK-MB - Product Description
Table 196: RapiDx Assay - CRP - Product Status
Table 197: RapiDx Assay - CRP - Product Description
Table 198: RapiDx Assay - cTN - Product Status
Table 199: RapiDx Assay - cTN - Product Description
Table 200: Sarissa-Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 201: SMARTChip - Product Status
Table 202: SMARTChip - Product Description
Table 203: SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
Table 204: cTnl Assay - Product Status
Table 205: cTnl Assay - Product Description
Table 206: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 207: Point-Of-Care Platform - Cardiac Disorders Assay - Product Status
Table 208: Point-Of-Care Platform - Cardiac Disorders Assay - Product Description
Table 209: ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 210: Diagnostic Test - Heart Attack - Product Status
Table 211: Diagnostic Test - Heart Attack - Product Description
Table 212: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 213: D-dimer Test - Product Status
Table 214: D-dimer Test - Product Description
Table 215: Multiplex Cardiac Panel - Product Status
Table 216: Multiplex Cardiac Panel - Product Description
Table 217: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 218: TrueDX - Cardiac Health Test - Product Status
Table 219: TrueDX - Cardiac Health Test - Product Description
Table 220: Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 221: GH Assay - Heart Failure - Product Status
Table 222: GH Assay - Heart Failure - Product Description
Table 223: IGFs Assay - Heart Failure - Product Status
Table 224: IGFs Assay - Heart Failure - Product Description
Table 225: NGAL-sp Test - Heart Failure - Product Status
Table 226: NGAL-sp Test - Heart Failure - Product Description
Table 227: TSH Assay - Heart Failure - Product Status
Table 228: TSH Assay - Heart Failure - Product Description
Table 229: Glossary
2.2 List of Figures
Figure 1: Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Cardiac Markers Rapid Tests & POC - Pipeline Products by Segment
Figure 3: Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
Figure 4: Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 5: Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us